釼持広知 (Hirotsugu Kenmotsu) - マイポータル

基本情報

所属: 静岡県立静岡がんセンター（研究所）その他部局等研究員

J-GLOBAL ID: 201801009977314998
researchmap会員ID: B000313461

研究分野

ライフサイエンス / 呼吸器内科学 /

論文

Correlation between cancer cachexia and psychosocial impact in older patients with advanced lung cancer undergoing chemotherapy.

Rika Sato, Tateaki Naito, Haruyasu Murakami, Shota Omori, Haruki Kobayashi, Akira Ono, Nobuaki Mamesaya, Kazushige Wakuda, Ryo Ko, Hirotsugu Kenmotsu …

Asia-Pacific journal of oncology nursing 12 100658-100658 2025年12月
Frequency of ischemic cardiac events in patients receiving long-term multikinase inhibitor: A report of three cases

Nao Muraoka, Takuya Oyakawa, Ayano Fujita, Kei Iida, Tomoya Yokota, Hirotsugu Kenmotsu

Asia-Pacific Journal of Oncology Nursing 12 100624-100624 2025年12月
Phase II study of afatinib for advanced non-small cell lung cancer with uncommon epidermal growth factor receptor mutations, including compound mutations detected by next-generation sequencing

Nobuaki Mamesaya, Keita Mori, Haruki Kobayashi, Shota Omori, Ryo Ko, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami …

International Journal of Clinical Oncology 30(9) 1787-1796 2025年7月6日
Current Status of Multimodal Therapy for Oligometastatic Disease, Induced Oligometastatic Disease, and Oligo-Progressive Disease in EGFR-Mutated Non-Small-Cell Lung Cancer.

Taichi Miyawaki, Hirotsugu Kenmotsu, Ryo Ko, Masaki Oshima, Takehito Shukuya, Naoto Shikama, Kazuhisa Takahashi

Cancers 17(13) 2025年6月30日
Desensitizing Effect of Intra‐Tumoral <scp>GDF</scp>‐15 on Immunotherapy in Patients With Advanced Non‐Small Cell Lung Cancer

Naoya Nishioka, Tateaki Naito, Takashi Sugino, Koji Muramatsu, Shigeki Nishihara, Hiroki Urashima, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Ryo Ko …

Thoracic Cancer 16(10) 2025年5月21日
Deterioration of performance status before administration of chemotherapy as a prognostic factor in untreated advanced non-small cell lung cancer.

Kenju Ando, Hirotsugu Kenmotsu, Yuichiro Nishibori, Akiko Tamura, Suguru Matsuda, Meiko Morita, Motoki Sekikawa, Kosei Doshita, Keita Miura, Hiroaki Kodama …

Cancer treatment and research communications 43 100915-100915 2025年
Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort study.

Noboru Morikawa, Tateaki Naito, Meiko Morita, Motoki Sekikawa, Kosei Doshita, Michitoshi Yabe, Hiroaki Kodama, Keita Miura, Yuko Iida, Nobuaki Mamesaya …

Journal of geriatric oncology 15(7) 101832-101832 2024年9月
Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study.

Kosei Doshita, Tateaki Naito, Suguru Matsuda, Meiko Morita, Motoki Sekikawa, Keita Miura, Hiroaki Kodama, Michitoshi Yabe, Noboru Morikawa, Yuko Iida …

Thoracic cancer 15(25) 1831-1841 2024年9月
Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.

Meiko Morita, Akira Ono, Motoki Sekikawa, Kosei Doshita, Keita Miura, Hiroaki Kodama, Michitoshi Yabe, Noboru Morikawa, Yuko Iida, Nobuaki Mamesaya …

Cancer reports (Hoboken, N.J.) 7(9) e70004 2024年9月
Suitability of frozen cell pellets from cytology specimens for the <scp>A</scp>moy 9‐in‐1 assay in patients with non‐small cell lung cancer

Hiroaki Kodama, Haruyasu Murakami, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Kazushige Wakuda, Ryo Ko, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito …

Thoracic Cancer 15(21) 1665-1672 2024年6月19日
Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis

Satoshi Ikeda, Takashi Ogura, Terufumi Kato, Hirotsugu Kenmotsu, Yoko Agemi, Takaaki Tokito, Kentaro Ito, Kohsuke Isomoto, Yuichi Takiguchi, Yasuto Yoneshima …

Annals of the American Thoracic Society 2024年2月16日
Efficacy of subsequent treatment for unresectable locally-advanced non-small cell lung cancer after relapse of concurrent chemoradiotherapy with durvalumab consolidation therapy: A single-center retrospective study.

Yuichiro Nishibori, Hirotsugu Kenmotsu, Kenju Ando, Ayumi Tonsho, Suguru Matsuda, Meiko Morita, Motoki Sekikawa, Kosei Doshita, Noboru Morikawa, Keita Miura …

Cancer treatment and research communications 41 100849-100849 2024年
Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS Study.

Satoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu, Takashi Ogura, Yuki Sato, Aoi Hino, Toshiyuki Harada, Kaoru Kubota, Takaaki Tokito, Isamu Okamoto …

The oncologist 2022年6月27日
Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society.

Yuichi Ozawa, Nobuyuki Yamamoto, Kouji Yamamoto, Kentaro Ito, Hirotsugu Kenmotsu, Hidetoshi Hayashi, Takehito Shukuya, Daichi Fujimoto, Shunichi Sugawara, Seiji Niho …

JTO clinical and research reports 3(5) 100317-100317 2022年5月
Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases.

Eriko Miyawaki, Hirotsugu Kenmotsu, Keita Mori, Hideyuki Harada, Koichi Mitsuya, Nobuaki Mamesaya, Takahisa Kawamura, Haruki Kobayashi, Kazuhisa Nakashima, Shota Omori …

International journal of radiation oncology, biology, physics 104(3) 604-613 2019年7月1日査読有り
Corrigendum to "Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer" [Lung Cancer 128 (2019) 152-157].

Ono A, Isaka M, Serizawa M, Omae K, Kojima H, Nakashima K, Omori S, Wakuda K, Kenmotsu H, Naito T …

Lung cancer (Amsterdam, Netherlands) 130 226-226 2019年4月査読有り
Leptomeningeal recurrence after long-term alectinib therapy for non-small cell lung cancer harboring an EML4-ALK fusion protein.

Kawamura T, Murakami H, Kobayashi H, Nakashima K, Omori S, Wakuda K, Ono A, Kenmotsu H, Naito T, Endo M …

Investigational new drugs 37(1) 184-187 2019年2月査読有り
Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer.

Ono A, Isaka M, Serizawa M, Omae K, Kojima H, Nakashima K, Omori S, Wakuda K, Kenmotsu H, Naito T …

Lung cancer (Amsterdam, Netherlands) 128 152-157 2019年2月査読有り
Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study.

Mitsuya K, Nakasu Y, Hayashi N, Deguchi S, Takahashi T, Murakami H, Naito T, Kenmotsu H, Ono A, Wakuda K …

PloS one 14(1) e0210074 2019年査読有り
Platinum Combination Chemotherapy Is Poorly Tolerated in Malnourished Advanced Lung Cancer Patients with Poor Performance Status.

Fujio T, Nakashima K, Naito T, Kobayashi H, Omori S, Wakuda K, Ono A, Kenmotsu H, Murakami H, Takahashi T

Nutrition and cancer 71(5) 1-5 2019年1月査読有り

もっとみる

MISC

高齢者EGFR遺伝子変異陽性の非小細胞肺癌患者に対するTDMに基づく低用量アファチニブの第II相試験

釼持広知, 釼持広知, 今村知世, 盛啓太, 豆鞘伸昭, 小林玄機, 大森翔太, 高遼, 和久田一茂, 小野哲 …

日本呼吸器学会誌(Web) 12 2023年
肺癌におけるHER2発現変化の検討

大森翔太, 大森翔太, 村松浩二, 河田卓也, 豆鞘伸昭, 小林玄機, 和久田一茂, 小野哲, 釼持広知, 内藤立暁 …

日本肺癌学会学術集会号(CD-ROM) 64th 2023年
進行非小細胞肺がん患者における,がん悪液質のプラチナ製剤併用療法+PD-1/PD-L1阻害薬の治療効果への影響

宮脇太一, 内藤立暁, 矢部道俊, 西岡直哉, 豆鞘伸昭, 大森翔太, 小林玄機, 和久田一茂, 小野哲, 釼持広知 …

日本がんサポーティブケア学会学術集会プログラム・抄録集(CD-ROM) 6th 2021年
進行非小細胞肺癌における腫瘍量のPD-1/PD-L1阻害剤+プラチナ併用化学療法の治療効果への影響

宮脇太一, 釼持広知, 豆鞘伸昭, 大森翔太, 小林玄機, 高遼, 和久田一茂, 小野哲, 内藤立暁, 村上晴泰 …

日本肺癌学会学術集会号(CD-ROM) 62nd 2021年
ALK遺伝子転座陽性進行非小細胞肺癌患者におけるペメトレキセドに対するALK-TKI治療歴の影響

矢部道俊, 釼持広知, 児玉裕章, 西岡直哉, 宮脇太一, 宮脇英里子, 豆鞘伸昭, 小林玄機, 大森翔太, 和久田一茂 …

日本肺癌学会学術集会号(CD-ROM) 62nd 2021年
Long-term clinical outcomes of ALK inhibitors in patients with ALK-positive advanced non-small cell lung cancer.

Haruyasu Murakami, Akira Ono, Kazuhisa Nakashima, Shota Omori, Kazushige Wakuda, Hirotsugu Kenmotsu, Tateaki Naito, Toshiaki Takahashi

JOURNAL OF CLINICAL ONCOLOGY 35 2017年5月
Nivolumab-induced interstitial lung disease (ILD) in Japanese patients with non-small cell lung cancer: A study on risk factors for fatal outcome.

Terufumi Kato, Fumikazu Sakai, Tomohisa Baba, Masahiko Kusumoto, Hirotsugu Kenmotsu, Hiroaki Sugiura, Junya Tominaga, Katsunori Oikado, Masafumi Sata, Masahiro Endo …

JOURNAL OF CLINICAL ONCOLOGY 35 2017年5月
Plasma epidermal growth factor receptor mutation (EGFR) testing in advanced non-small-cell lung cancer patients harboring EGFR mutations by chip-based digital PCR system

Norimitsu Kasahara, Hirotsugu Kenmotsu, Masakuni Serizawa, Rina Umehara, Akira Ono, Kazushige Wakuda, Shota Omori, Kazuhisa Nakashima, Tetsuhiko Taira, Tateaki Naito …

CANCER RESEARCH 76 2016年7月
Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

Hirotsugu Kenmotsu, Yusuke Tanigawara

CANCER SCIENCE 106(5) 497-504 2015年5月
RELATIONSHIP OF PROGRESSION-FREE SURVIVAL, POST-PROGRESSION SURVIVAL AND RESPONSE WITH OVERALL SURVIVAL IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER OF INDIVIDUAL-LEVEL

Hisao Imai, Keita Mori, Akira Ono, Hiroaki Akamatsu, Takehito Shukuya, Tetsuhiko Taira, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Masahiro Endo …

RESPIROLOGY 18 85-85 2013年11月
PHARMACOGENETIC STUDY OF JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITH PEMETREXED PLUS CISPLATIN

Hisao Imai, Toshiaki Takahashi, Masakuni Serizawa, Keita Mori, Akira Ono, Hiroaki Akamatsu, Tetsuhiko Taira, Yukiko Nakamura, Hirotsugu Kenmotsu, Tateaki Naito …

JOURNAL OF THORACIC ONCOLOGY 8 S1077-S1077 2013年11月
Pharmacogenetic study of Japanese patients with advanced nonsquamous non-small cell lung cancer treated with pemetrexed plus cisplatin

Hisao Imai, Masakuni Serizawa, Toshiaki Takahashi, Keita Mori, Akira Ono, Hiroaki Akamatsu, Tetsuhiko Taira, Yukiko Nakamura, Hirotsugu Kenmotsu, Tateaki Naito …

JOURNAL OF CLINICAL ONCOLOGY 31(15) 2013年5月
悪性胸膜中皮腫に対するシスプラチン+ペメトレキセド療法とシスプラチン+ゲムシタビン療法の比較検討

宿谷威仁, 高橋利明, 時任高章, 今井久雄, 小野哲, 赤松弘朗, 太良哲彦, 釼持広知, 内藤立暁, 村上晴泰 …

日本呼吸器学会誌 2(増刊) 330-330 2013年3月
進展型小細胞肺癌における、初回化学療法後に出現した脳転移が予後に与える影響の検討

和久田一茂, 釼持広知, 赤松弘朗, 小野哲, 宿谷威仁, 太良哲彦, 内藤立暁, 村上晴泰, 高橋利明, 遠藤正浩 …

肺癌 52(5) 586-586 2012年10月
進行非扁平上皮NSCLCに対する初回CDDP+PEM(CP)療法後の全生存期間(OS)と増悪後生存期間(PPS)との相関

今井久雄, 高橋利明, 木村円花, 時任高章, 小野哲, 赤松弘朗, 宿谷威仁, 太良哲彦, 釼持広知, 内藤立暁 …

肺癌 52(5) 617-617 2012年10月
進行肺腺癌における予後因子としての血清シフラの検討

小野哲, 高橋利明, 木村円花, 時任高章, 今井久雄, 久松靖史, 釼持広知, 太良哲彦, 赤松弘朗, 宿谷威仁 …

肺癌 52(5) 595-595 2012年10月